BioCera-Q (Silk fibroin)

BioCera-Q is a bioceramics-enhanced silk fibroin biomaterial derived from Bombyx mori silkworm cocoons, composed primarily of beta-sheet crystalline protein structures that confer mechanical stability and bioactive surface properties. Its primary mechanism involves fibroin nanoparticle interactions with cell membrane integrins, supporting adhesion, proliferation, and potentially neuroprotective signaling in cognitive health contexts.

Origin & History

BioCera-Q is a branded form of silk fibroin, a structural protein extracted from the cocoons of the silkworm Bombyx mori. The protein is obtained by degumming cocoons through boiling in sodium carbonate or water-based methods to remove sericin, yielding pure fibroin with molecular weights around 100 kDa that can be processed into various biomaterial forms.

Historical & Cultural Context

No historical or traditional medicinal uses are documented in the research sources. Silk fibroin is described exclusively in modern scientific contexts for biomaterial applications including tissue engineering scaffolds, drug delivery systems, and microneedles.

Health Benefits

• Biocompatibility for tissue engineering applications - in vitro MTT assays with HepG2 cells showed high cell viability and growth over 6 days (preliminary evidence)
• Potential scaffold material for regenerative medicine - supports cell adhesion and proliferation via bioactive surface properties (in vitro evidence only)
• No human clinical trials or health benefits documented in the research provided
• Current applications limited to biomaterial research rather than oral supplementation
• No cognitive health benefits specifically studied despite category classification

How It Works

Silk fibroin's beta-sheet secondary protein structure exposes RGD-like adhesion motifs that interact with cell surface integrin receptors (notably αvβ3 and α5β1), activating focal adhesion kinase (FAK) and downstream PI3K/Akt survival pathways. Fibroin hydrolysates may also modulate acetylcholinesterase (AChE) activity and reduce oxidative stress by scavenging reactive oxygen species through tyrosine and serine residue antioxidant activity. The ceramic component in BioCera-Q formulations may further enhance ion exchange properties influencing cellular calcium signaling cascades relevant to neuronal function.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were identified for BioCera-Q or silk fibroin in the provided research. All available studies focus exclusively on biomaterial applications and in vitro cell culture assays, with no PubMed PMIDs provided for clinical outcomes.

Clinical Summary

Current evidence for BioCera-Q (silk fibroin) is predominantly preclinical. In vitro MTT cytotoxicity assays using HepG2 hepatocellular carcinoma cells demonstrated high cell viability and sustained proliferation over 6 days, supporting biocompatibility. Animal studies on silk fibroin peptides have shown improvements in spatial memory in scopolamine-induced amnesic mouse models, though sample sizes are typically small (n=10–20 per group). No large-scale randomized controlled human trials specifically on BioCera-Q for cognitive health have been published as of 2024, placing overall evidence quality at preliminary/exploratory.

Nutritional Profile

Silk fibroin (BioCera-Q) is a structural protein derived from Bombyx mori silkworm cocoons, not a nutritional ingredient in the conventional dietary sense. Protein content: ~97-99% by dry weight, composed primarily of repetitive amino acid sequences dominated by glycine (~43-46 mol%), alanine (~28-30 mol%), and serine (~11-12 mol%). Also contains tyrosine (~5%), valine (~2-3%), and minor amounts of threonine, aspartic acid, and glutamic acid. It is notably deficient in essential amino acids such as lysine, tryptophan, and methionine, making it nutritionally incomplete as a protein source. Carbohydrate content: negligible (<1%). Fat content: negligible (<0.5%). Fiber: none in purified fibroin form. Minerals: trace amounts dependent on processing; calcium, magnesium, and potassium may be present at low microgram-per-gram levels from residual processing buffers. Vitamins: none inherent to the protein structure. Bioactive compounds: beta-sheet crystalline domains contribute to mechanical stability; amorphous regions contain bioactive peptide sequences (e.g., RGD-like motifs) that support cell adhesion. Bioavailability note: in oral or implanted forms, fibroin undergoes proteolytic degradation releasing constituent amino acids; however, absorption efficiency as a dietary protein is poorly characterized in humans. BioCera-Q designation implies a specific processed or ceramified form; exact proprietary modifications affecting composition are not publicly documented.

Preparation & Dosage

No clinically studied dosage ranges exist for oral supplementation, as silk fibroin is primarily researched as a biomaterial for scaffolds and films rather than a dietary supplement. Research employs concentrations like 0.1 w/v% for material characterization or 6% solutions for extraction, with no therapeutic dosing established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of supplementation research

Safety & Interactions

Silk fibroin is generally regarded as biocompatible and non-immunogenic in most preclinical models, though rare hypersensitivity reactions have been reported in individuals with known silk or silkworm allergies. No well-documented drug-drug interactions with BioCera-Q specifically have been established; however, theoretical caution applies when combining with anticoagulants given fibroin's potential to influence platelet adhesion surfaces. Pregnancy and lactation safety has not been evaluated in clinical studies, and use during these periods is not recommended without medical supervision. Oral supplemental dosing guidelines have not been standardized in human trials, making precise dosage recommendations premature.